# SNDL Inc.: financial statements, quarterly

SNDL · Nasdaq · CIK 1766600 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sndl.md) · [Financials](/companies/sndl/financials.md) · [Filings](/companies/sndl/filings.md) · [Insiders](/companies/sndl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sndl/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-02-28) | period not labelled (2018-02-28) | period not labelled (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.7](/filings/0001564590-20-014358.md) | [7.7](/filings/0001564590-21-013936.md) | [14.1](/filings/0001564590-22-016195.md) | [45.3](/filings/0000950170-24-034351.md) | [60.4](/filings/0000950170-24-034351.md) | [558](/filings/0000950170-24-034394.md) | [280](/filings/0000950170-25-040545.md) | [195](/filings/0001193125-26-102524.md) | [218](/filings/0001193125-26-102524.md) | [252](/filings/0001193125-26-102524.md) |
| Current assets | $m | not reported | not reported | [21.7](/filings/0001564590-20-014358.md) | [173](/filings/0001564590-21-013936.md) | [118](/filings/0001564590-22-016195.md) | [728](/filings/0000950170-24-034351.md) | [501](/filings/0000950170-24-034394.md) | [407](/filings/0000950170-25-040545.md) | [462](/filings/0001193125-26-102524.md) | [450](/filings/0001193125-26-102524.md) |
| Total assets | $m | not reported | not reported | [110](/filings/0001564590-20-014358.md) | [510](/filings/0001564590-21-013936.md) | [295](/filings/0001564590-22-016195.md) | [1,428](/filings/0000950170-24-034351.md) | [1,559](/filings/0000950170-24-034394.md) | [1,473](/filings/0000950170-25-040545.md) | [1,349](/filings/0001193125-26-102524.md) | [1,336](/filings/0001193125-26-102524.md) |
| Current liabilities | $m | not reported | not reported | [69.7](/filings/0001564590-20-014358.md) | [269](/filings/0001564590-21-013936.md) | [24.1](/filings/0001564590-22-016195.md) | [65.9](/filings/0000950170-24-034351.md) | [89.4](/filings/0000950170-24-034394.md) | [103](/filings/0000950170-25-040545.md) | [90.6](/filings/0001193125-26-102524.md) | [92.2](/filings/0001193125-26-102524.md) |
| Total liabilities | $m | not reported | not reported | [118](/filings/0001564590-20-014358.md) | [289](/filings/0001564590-21-013936.md) | [25.2](/filings/0001564590-22-016195.md) | [98.1](/filings/0000950170-24-034351.md) | [232](/filings/0000950170-24-034394.md) | [244](/filings/0000950170-25-040545.md) | [216](/filings/0001193125-26-102524.md) | [235](/filings/0001193125-26-102524.md) |
| Shareholders' equity | $m | [11.5](/filings/0001564590-20-014358.md) | [13.7](/filings/0001564590-21-013936.md) | [(7.9)](/filings/0001564590-20-014358.md) | [216](/filings/0001564590-21-013936.md) | [272](/filings/0001564590-22-016195.md) | [1,329](/filings/0000950170-24-034351.md) | [1,306](/filings/0000950170-24-034394.md) | [1,212](/filings/0000950170-25-040545.md) | [1,133](/filings/0001193125-26-102524.md) | [1,101](/filings/0001193125-26-102524.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 263,359,123 at 2025-12-31, from the cover of the [40-F filed 2026-03-12](/filings/0001193125-26-102524.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.